PNC FINANCIAL SERVICES GROUP, INC. - COLLPLANT BIOTECHNOLOGIES LT ownership

COLLPLANT BIOTECHNOLOGIES LT's ticker is CLGN and the CUSIP is M2R51X116. A total of 21 filers reported holding COLLPLANT BIOTECHNOLOGIES LT in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of COLLPLANT BIOTECHNOLOGIES LT
ValueSharesWeighting
Q3 2023$20,052
-31.7%
3,6000.0%0.00%
Q2 2023$29,376
+16.2%
3,6000.0%0.00%
Q1 2023$25,272
-15.9%
3,6000.0%0.00%
Q4 2022$30,060
+25.2%
3,6000.0%0.00%
Q3 2022$24,000
-14.3%
3,6000.0%0.00%
Q2 2022$28,000
-30.0%
3,6000.0%0.00%
Q1 2022$40,000
-31.0%
3,6000.0%0.00%
Q4 2021$58,0003,6000.00%
Other shareholders
COLLPLANT BIOTECHNOLOGIES LT shareholders Q3 2022
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 577,909$4,056,9219.19%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 463,899$3,256,5710.62%
VILLERE ST DENIS J & CO LLC 289,797$2,034,3740.15%
BENJAMIN F. EDWARDS & COMPANY, INC. 65,911$4630.02%
Shay Capital LLC 10,000$70,2000.01%
SIMON QUICK ADVISORS, LLC 13,202$92,6780.01%
Zurcher Kantonalbank (Zurich Cantonalbank) 23,120$162,3020.00%
BROWN ADVISORY INC 73,849$518,4200.00%
Geneos Wealth Management Inc. 750$5,2650.00%
Focused Wealth Management, Inc 242$1,6990.00%
View complete list of COLLPLANT BIOTECHNOLOGIES LT shareholders